411 related articles for article (PubMed ID: 30828083)
1. Successful Third Kidney Transplant After Desensitization for Combined Human Leucocyte Antigen (HLA) and ABO Incompatibility: A Case Report and Review of Literature.
Thukral S; Shinde N; Mukherjee K; Ray DS
Am J Case Rep; 2019 Mar; 20():285-289. PubMed ID: 30828083
[TBL] [Abstract][Full Text] [Related]
2. ABO-Incompatible Renal Transplantation with High Antibody Titer: A Case Report.
Ray DS; Thukral S
Am J Case Rep; 2017 Oct; 18():1073-1076. PubMed ID: 28983073
[TBL] [Abstract][Full Text] [Related]
3. Long-term desensitization for ABO-incompatible living related kidney transplantation recipients with high refractory and rebound anti-blood type antibody: case report.
Nishimura H; Yamada Y; Hisano S; Mitsuke A; Tatarano S; Gotanda T; Hayami H; Nakagawa M; Enokida H
BMC Nephrol; 2018 Oct; 19(1):254. PubMed ID: 30290778
[TBL] [Abstract][Full Text] [Related]
4. Outcome of desensitization in human leukocyte antigen- and ABO-incompatible living donor kidney transplantation: a single-center experience in more than 100 patients.
Al Meshari K; Pall A; Chaballout A; El Gamal H; Al Mana H; Humaidan H; Alzayer F; Al Talhi M
Transplant Proc; 2013 May; 45(4):1423-6. PubMed ID: 23726587
[TBL] [Abstract][Full Text] [Related]
5. Outcome of Desensitization Therapy in Immunologically High-Risk Kidney Transplantation: Single-Center Experience.
Sinangil A; Ucar ZA; Koc Y; Barlas S; Abouzahir S; Ecder ST; Akin EB
Transplant Proc; 2019 Sep; 51(7):2268-2273. PubMed ID: 31358450
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of ABO-incompatible kidney transplant with rituximab and double-filtration plasmapheresis.
Han S; Hwang E; Park S; Park U; Kim H; Cho W
Exp Clin Transplant; 2014 Oct; 12(5):401-4. PubMed ID: 25299367
[TBL] [Abstract][Full Text] [Related]
7. Tailored desensitization strategies in ABO blood group antibody incompatible renal transplantation.
Barnett AN; Manook M; Nagendran M; Kenchayikoppad S; Vaughan R; Dorling A; Hadjianastassiou VG; Mamode N
Transpl Int; 2014 Feb; 27(2):187-96. PubMed ID: 24188566
[TBL] [Abstract][Full Text] [Related]
8. Successful desensitization and kidney transplantation in the presence of donor-specific anti-human leukocyte antigen antibodies in kidney transplant recipients.
Khan MT; Hamid RB; Sarfaraz S; Lal N; Ahmed J; Luxmi S
Saudi J Kidney Dis Transpl; 2020; 31(6):1432-1438. PubMed ID: 33565460
[TBL] [Abstract][Full Text] [Related]
9. Desensitization with plasmapheresis and anti-Cd20 for ABO incompatible kidney transplantation from living donor: experience of a single center in Italy.
Silvestre C; Furian L; Marson P; Tison T; Valente M; Marchini F; Rossi B; Bonfante L; Valerio F; Cozzi E; Rigotti P
Transplant Proc; 2014 Sep; 46(7):2209-13. PubMed ID: 25242753
[TBL] [Abstract][Full Text] [Related]
10. Frequent development of subclinical chronic antibody-mediated rejection within 1 year after renal transplantation with pre-transplant positive donor-specific antibodies and negative CDC crossmatches.
Yamanaga S; Watarai Y; Yamamoto T; Tsujita M; Hiramitsu T; Nanmoku K; Goto N; Takeda A; Morozumi K; Katayama A; Saji H; Uchida K; Kobayashi T
Hum Immunol; 2013 Sep; 74(9):1111-8. PubMed ID: 23792054
[TBL] [Abstract][Full Text] [Related]
11. Successful unintentional ABO-incompatible renal transplantation: Blood group A1B donor into an A2B recipient.
Fadeyi EA; Stratta RJ; Farney AC; Pomper GJ
Am J Clin Pathol; 2014 May; 141(5):724-6. PubMed ID: 24713746
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of ABO-incompatible living kidney transplantation: a single-center experience.
Tanabe K; Takahashi K; Sonda K; Tokumoto T; Ishikawa N; Kawai T; Fuchinoue S; Oshima T; Yagisawa T; Nakazawa H; Goya N; Koga S; Kawaguchi H; Ito K; Toma H; Agishi T; Ota K
Transplantation; 1998 Jan; 65(2):224-8. PubMed ID: 9458019
[TBL] [Abstract][Full Text] [Related]
13. Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers.
Warren DS; Zachary AA; Sonnenday CJ; King KE; Cooper M; Ratner LE; Shirey RS; Haas M; Leffell MS; Montgomery RA
Am J Transplant; 2004 Apr; 4(4):561-8. PubMed ID: 15023148
[TBL] [Abstract][Full Text] [Related]
14. Desensitization Before Living Donor Kidney Transplantation in Highly HLA-Sensitized Patients: A Single-Center Study.
De Sousa-Amorim E; Revuelta I; Blasco M; Diekmann F; Cid J; Lozano M; Sánchez-Escuredo A; Martorell J; Palou E; Campistol JM; Oppenheimer F
Transplant Proc; 2015 Oct; 47(8):2332-5. PubMed ID: 26518919
[TBL] [Abstract][Full Text] [Related]
15. Isoagglutinin adsorption in ABO-incompatible transplantation.
Genberg H; Kumlien G; Wennberg L; Tydén G
Transfus Apher Sci; 2010 Oct; 43(2):231-5. PubMed ID: 20667787
[TBL] [Abstract][Full Text] [Related]
16. Outcome of ABO-Incompatible Living Donor Renal Transplantations: A Single-Center Experience From Eastern India.
Ray DS; Thukral S
Transplant Proc; 2016 Oct; 48(8):2622-2628. PubMed ID: 27788792
[TBL] [Abstract][Full Text] [Related]
17. Outcome of desensitization in human leukocyte antigen and ABO incompatible living donor kidney transplantation: Single center experience of first 200 incompatible transplants.
Pandey P; Setya D; Sinha VK; Devra AK; Bhatt AP; Pande A; Kumar P; Singh MK; Ranjan S
J Clin Apher; 2021 Jun; 36(3):299-312. PubMed ID: 33316838
[TBL] [Abstract][Full Text] [Related]
18. A case report of successful renal transplantation in an ABO incompatible patient with a preformed donor-specific antibody and negative CDC human leukocyte antigens crossmatch.
Chowdhry M; Makroo RN; Kakkar B; Jasuja S; Sagar G; Thakur Y
Saudi J Kidney Dis Transpl; 2018; 29(3):698-704. PubMed ID: 29970748
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of cellular and humoral immunity in a successful case of positive crossmatch kidney transplantation: a case report.
Tanimine N; Ide K; Yamashita M; Tanaka Y; Igarashi Y; Banshodani M; Tazawa H; Basnet NB; Doskali M; Onoe T; Tashiro H; Ohdan H
Transplant Proc; 2011; 43(6):2411-4. PubMed ID: 21839279
[TBL] [Abstract][Full Text] [Related]
20. ABO-incompatible transplantation without conventional induction immunosuppression (IL-2RB or depleting agents).
Hafeeq B; Aziz F; Narayanan S; Aboobacker IN; Gopinathan JC; Narayanan R; Binu JJ; Uvais NA
Saudi J Kidney Dis Transpl; 2020; 31(3):572-581. PubMed ID: 32655043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
